Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$4.99 - $7.46 $156,606 - $234,124
-31,384 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$7.16 - $9.69 $733,241 - $992,333
-102,408 Reduced 76.54%
31,384 $225,000
Q2 2021

Aug 11, 2021

BUY
$6.23 - $10.03 $111,417 - $179,376
17,884 Added 15.43%
133,792 $1.24 Million
Q1 2021

May 17, 2021

BUY
$8.81 - $16.96 $1.02 Million - $1.97 Million
115,908 New
115,908 $1.08 Million

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $459M
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.